Pediatric Study Of Leuprolide Test, Obesity Devices To Be Discussed By Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Protocol for leuprolide (TAP's Lupron) test of puberty disorders rejected by University of Chicago IRB to be reviewed by FDA's Pediatric Ethics Subcommittee.